Psychedelics Archives

FAQ: Timeline for FDA ibogaine approval

FAQ by Gregory Ferenstein

Psychedelic treatment for neurodegenerative disorders

Policy Brief by Madison Carlino

Ibogaine treatment for opioid use disorder

Policy Brief by Madison Carlino

A policy framework for personal psychedelics licenses

Policy Brief by Gregory Ferenstein

Modernizing psilocybin policy to improve mental health outcomes

Policy Brief by Madison Carlino